ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
8 018,16
0,32%
Dow Jones
38 686,32
1,51%
DAX
18 602,64
0,65%
Brent Oil
81,185
0,47%
Bitcoin
68 828,55
1,59%
Registration Strip Icon for charts Inscrivez-vous pour des graphiques en temps réel, des outils d'analyse et des prix.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. CTI BioPharma Corporation (CTIC)

  7. CTI BioPharma Corporation (CTIC) Actualités

CTIC

CTI BioPharma (CTIC)

CTI BioPharma Corporation
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:CTIC
DateHeureSourceTitreSymboleSociété
06/07/202322h15Edgar (US Regulatory)Form 15-12G - Securities registration termination [Section 12(g)]NASDAQ:CTICCTI BioPharma Corporation
30/06/202312h08Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:CTICCTI BioPharma Corporation
30/06/202306h15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:CTICCTI BioPharma Corporation
29/06/202300h27Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CTICCTI BioPharma Corporation
29/06/202300h26Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CTICCTI BioPharma Corporation
28/06/202319h51Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NASDAQ:CTICCTI BioPharma Corporation
26/06/202323h07Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:CTICCTI BioPharma Corporation
26/06/202322h25Edgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)NASDAQ:CTICCTI BioPharma Corporation
26/06/202316h35Edgar (US Regulatory)Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or Retired Securities Initial Filing Amendments (25-nse)NASDAQ:CTICCTI BioPharma Corporation
26/06/202315h21Edgar (US Regulatory)Amended Tender Offer Statement by Third Party (sc To-t/a)NASDAQ:CTICCTI BioPharma Corporation
26/06/202314h52Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CTICCTI BioPharma Corporation
26/06/202312h08Edgar (US Regulatory)Amended Statement of Ownership: Solicitation (sc 14d9/a)NASDAQ:CTICCTI BioPharma Corporation
24/06/202312h51PR Newswire (US)Sobi successfully completes tender offer for all outstanding shares of common stock of CTI BioPharma Corp.NASDAQ:CTICCTI BioPharma Corporation
30/05/202322h35PR Newswire (US)CTI BioPharma Announces Cancellation of its 2023 Annual Meeting of StockholdersNASDAQ:CTICCTI BioPharma Corporation
25/05/202313h01Edgar (US Regulatory)Statement of Ownership: Solicitation (sc 14d9)NASDAQ:CTICCTI BioPharma Corporation
25/05/202312h46Edgar (US Regulatory)Tender Offer Statement by Third Party (sc To-t)NASDAQ:CTICCTI BioPharma Corporation
15/05/202322h29Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:CTICCTI BioPharma Corporation
10/05/202320h03Edgar (US Regulatory)Written Communication by the Subject Company Relating to a Third Party Tender Offer (sc14d9c)NASDAQ:CTICCTI BioPharma Corporation
10/05/202307h06PR Newswire (US)Sobi to Acquire CTI BioPharmaNASDAQ:CTICCTI BioPharma Corporation
05/05/202301h55PR Newswire (US)CTI BioPharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:CTICCTI BioPharma Corporation
01/05/202322h46PR Newswire (US)CTI BioPharma To Report First Quarter 2023 Financial Results and Provide Corporate Update on Thursday, May 11, 2023NASDAQ:CTICCTI BioPharma Corporation
01/05/202313h03PR Newswire (US)CTI BioPharma Announces Two Abstracts Accepted for Presentation at the 2023 American Society of Clinical Oncology (ASCO) Annual MeetingNASDAQ:CTICCTI BioPharma Corporation
28/04/202322h14Edgar (US Regulatory)Annual Report to Security Holders (ars)NASDAQ:CTICCTI BioPharma Corporation
28/04/202322h08Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:CTICCTI BioPharma Corporation
14/04/202314h26Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:CTICCTI BioPharma Corporation
12/04/202322h30PR Newswire (US)CTI BioPharma to Participate in Two Upcoming Investor Conferences in April 2023NASDAQ:CTICCTI BioPharma Corporation
06/03/202322h32Edgar (US Regulatory)Annual Report (10-k)NASDAQ:CTICCTI BioPharma Corporation
06/03/202312h25PR Newswire (US)CTI BioPharma Reports Fourth Quarter and Full Year 2022 Financial ResultsNASDAQ:CTICCTI BioPharma Corporation
01/03/202322h20PR Newswire (US)CTI BioPharma to Present at the 43rd Annual Cowen Health Care ConferenceNASDAQ:CTICCTI BioPharma Corporation
23/02/202313h03PR Newswire (US)CTI BioPharma To Report Fourth Quarter and Full Year 2022 Financial Results and Provide Corporate Update on Monday, March 6, 2023NASDAQ:CTICCTI BioPharma Corporation
 Showing the most relevant articles for your search:NASDAQ:CTIC

Dernières Valeurs Consultées

USOTC
BDRAF
Bombardier (QX)
COIN
KEYFIUSD
KeyFi Token
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés